Impact of time to surgery after neoadjuvant chemotherapy in operable breast cancer patients.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  European Journal of Surgical Oncology

• Publication date

  2017-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.ejso.2016.09.020PMID 27793416
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

  2019cited by this paper
• Impact of Time from Completion of Neoadjuvant Chemotherapy to Surgery on Survival Outcomes in Breast Cancer Patients

  2016cited by this paper
• Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

  2015cited by this paper
• Clinical impact of delaying initiation of adjuvant chemotherapy in patients with breast cancer.

  2014cited by this paper
• Neoadjuvant therapy in the treatment of breast cancer.

  2014cited by this paper
• The requirements of a specialist Breast Centre.

  2013cited by this paper
• Defining the benefits of neoadjuvant chemotherapy for breast cancer.

  2012cited by this paper
• Neoadjuvant treatment of breast cancer.

  2012cited by this paper
• Impact on survival of time from definitive surgery to initiation of adjuvant chemotherapy for early-stage breast cancer.

  2006cited by this paper
• Influence of Timing of Initiation of Adjuvant Chemotherapy Over Survival in Breast Cancer: A Negative Outcome Study by the Spanish Breast Cancer Research Group (GEICAM)

  2006cited by this paper
• Does timing of adjuvant chemotherapy influence the prognosis after early breast cancer? Results of the Danish Breast Cancer Cooperative Group (DBCG)

  2005cited by this paper
• Does timing of adjuvant chemotherapy for early breast cancer influence survival?

  2003cited by this paper
• Early start of adjuvant chemotherapy may improve treatment outcome for premenopausal breast cancer patients with tumors not expressing estrogen receptors. The International Breast Cancer Study Group.

  2000cited by this paper
• Evolving concepts in the systemic drug therapy of breast cancer.

  1997cited by this paper
• Effect of local or systemic treatment prior to primary tumor removal on the production and response to a serum growth-stimulating factor in mice.

  1989cited by this paper
• Effect of timing of initiation of adjuvant chemotherapy on disease-free survival in breast cancer

  1982cited by this paper

• Impact of Time to Surgery Post Neoadjuvant Chemotherapy on Breast Cancer Outcomes: A Retrospective Study of Patients Enrolled in the I-SPY 2 Clinical Trial

  2025cites this paper
• Influence of surgical timing post-neoadjuvant chemotherapy on survival outcomes in breast cancer patients: A comprehensive systematic review and meta-analysis

  2025cites this paper
• Progress in surgical management strategies after neoadjuvant therapy in breast cancer

  2025cites this paper
• Effect of Interval Between Neoadjuvant Chemotherapy and Surgery on Oncological Outcomes in Poor Responders With Locally Advanced Breast Cancer

  2024cites this paper
• Time to surgery after completion of neoadjuvant chemotherapy does not negatively impact recurrence and survival outcomes in breast cancer patients.

  2024cites this paper
• Impact of treatment interval between neoadjuvant immunochemotherapy and surgery in lung squamous cell carcinoma

  2024cites this paper
• Textbook Neoadjuvant Outcome—Novel Composite Measure of Oncological Outcomes among Gastric Cancer Patients Undergoing Multimodal Treatment

  2024cites this paper
• Clinical impact of delaying initiation of adjuvant chemotherapy in patients with early triple negative breast cancer

  2024cites this paper
• Neoadjuvant pertuzumab plus trastuzumab in combination with chemotherapy for human epidermal growth factor receptor 2 positive breast cancer: a real-world retrospective single-institutional study in China

  2024cites this paper
• Analyzing the Interaction between Time to Surgery and Tumor Burden Score in Hepatocellular Carcinoma.

  2024cites this paper
• Cross-modal deep learning model for predicting pathologic complete response to neoadjuvant chemotherapy in breast cancer

  2024cites this paper
• The optimal timing between neoadjuvant therapy and surgery of breast cancer: a brief systematic review of the literature.

  2023cites this paper
• Optimal Time Interval between Neoadjuvant Platinum-Based Chemotherapy and Interval Debulking Surgery in High-Grade Serous Ovarian Cancer

  2023cites this paper
• Does timing of neoadjuvant chemotherapy influence the prognosis in patients with early triple negative breast cancer?

  2023cites this paper
• Timing of interval debulking surgery and postoperative chemotherapy after neoadjuvant chemotherapy in advanced epithelial ovarian cancer: a multicenter real-world study

  2023cites this paper
• Impact of the Interval between Neoadjuvant Chemotherapy and Gastrectomy on Pathological Response and Survival Outcomes for Patients with Locally Advanced Gastric Cancer: A Meta-analysis

  2023cites this paper
• Optimizing postoperative outcomes following neoadjuvant chemotherapy and mastectomy with immediate reconstruction: A national analysis

  2023influential citation
• An appropriate treatment interval does not affect the prognosis of patients with breast Cancer

  2022cites this paper
• Time to treatment and hospital visits for patients undergoing neoadjuvant chemotherapy for breast cancer in a single payer system

  2022cites this paper
• Short-Term Outcomes Following Breast Cancer Surgery With and Without Neoadjuvant Chemotherapy: A Nationwide Administrative Database Study in Japan

  2022cites this paper
• ASO Author Reflections: Neoadjuvant Chemotherapy Does Not Affect Short-Term Outcomes After Breast Cancer Surgery

  2022cites this paper
• Safety of pre- or postoperative accelerated radiotherapy in 5 fractions: A randomized pilot trial

  2022cites this paper
• Surgical timing after preoperative chemotherapy is associated with oncologic outcomes in resectable colorectal liver metastases

  2022cites this paper
• Retrospective audit on time to surgery delays following the completion of neoadjuvant chemotherapy in breast cancer patients

  2022cites this paper
• Multidisciplinary considerations in the management of breast cancer patients receiving neoadjuvant chemotherapy.

  2022cites this paper
• Impact of the interval between neoadjuvant immunochemotherapy and surgery on surgical–pathological outcomes in non-small cell lung cancer

  2022cites this paper
• The effect of delayed treatment in breast cancer patients: How much is too late? An experience of a single-center study effect of surgery delay in survival.

  2022cites this paper
• Time to surgery and survival in breast cancer

  2022influential citation
• The significance of time interval between perioperative SOX/XELOX chemotherapy and clinical decision model in gastric cancer

  2022cites this paper
• Early Locoregional Breast Surgery and Survival in de novo Metastatic Breast Cancer in the Multicenter National ESME Cohort

  2021cites this paper
• Effect of time to breast cancer surgery after neoadjuvant chemotherapy on survival outcomes

  2021cites this paper
• Impact of the Interval Between Neoadjuvant Chemotherapy and Gastrectomy on Short- and Long-Term Outcomes for Patients with Advanced Gastric Cancer

  2021influential citation
• Young Women with Breast Cancer: Chemotherapy or Surgery First? An Evaluation of Time to Treatment for Invasive Breast Cancer

  2021cites this paper
• Neoadjuvant therapy for breast cancer patients and its impact on surgical treatment and radiotherapy (part 2.)

  2021cites this paper
• Breast cancer

  2021cites this paper
• Management of early-stage breast cancer patients during the coronavirus disease 2019 (COVID-19) pandemic: The experience in China from a surgical standpoint

  2021cites this paper
• Optimal timing of surgery following breast cancer neoadjuvant chemotherapy: A systematic review and meta-analysis.

  2021cites this paper
• How Long is It Safe to Wait for Breast Surgery After Completion of Neoadjuvant Chemotherapy?

  2021cites this paper
• Critical evaluation of factors contributing to time to mastectomy within a single health care system

  2020cites this paper
• Time to surgery among women treated with neoadjuvant systemic therapy and upfront surgery for breast cancer

  2020cites this paper
• Does the Timing of Surgery after Neoadjuvant Therapy in Breast Cancer Patients Affect the Outcome?

  2020cites this paper
• Time from Completion of Neo‐adjuvant Chemotherapy to Surgery: Effects on Outcomes in Breast Cancer Patients

  2020cites this paper
• Impact of delayed neoadjuvant systemic chemotherapy on overall survival among breast cancer patients.

  2020cites this paper
• Treatment for breast cancer patients during the special period of novel coronavirus pneumonia outbreak

  2020cites this paper
• Optimal Timing to Surgery After Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancer

  2020cites this paper
• Surgical timing following neoadjuvant chemotherapy for breast cancer affects postoperative complication rates.

  2020cites this paper
• Time to surgery following neoadjuvant chemotherapy for breast cancer impacts residual cancer burden, recurrence, and survival

  2020influential citation
• Aspects of Anesthesia for Breast Surgery during Pregnancy.

  2020cites this paper
• The relationship between time to surgery(TTS) after neoadjuvant chemotherapy (NAC)and survival in breast cancer patients: meta-analysis

  2020cites this paper
• The relationship between time to surgery after neoadjuvant chemotherapy and survival in breast cancer patients:a meta-analysis

  2020influential citation
• CMAR_A_216034 9563..9569

  2019cites this paper
• Predictive Role Of Body Composition Parameters In Operable Breast Cancer Patients Treated With Neoadjuvant Chemotherapy

  2019cites this paper
• Multiparametric MRI-based radiomics analysis for prediction of breast cancers insensitive to neoadjuvant chemotherapy

  2019cites this paper
• The prolonged interval between induction chemotherapy and radiotherapy is associated with poor prognosis in patients with nasopharyngeal carcinoma

  2019cites this paper
• Highlights of the 16th St Gallen International Breast Cancer Conference, Vienna, Austria, 20–23 March 2019: personalised treatments for patients with early breast cancer

  2019cites this paper
• Impact of the Time Interval from Neoadjuvant Chemotherapy to Surgery in Primary Ovarian, Tubal, and Peritoneal Cancer Patients

  2018cites this paper
• Impact of the time interval from completion of neoadjuvant chemotherapy to initiation of postoperative adjuvant chemotherapy on the survival of patients with advanced ovarian cancer.

  2018cites this paper
• Impact of time to surgery in the outcome of patients with liver resection for BCLC 0-A stage hepatocellular carcinoma.

  2017cites this paper
• Optimal Timing of Surgery after Neoadjuvant Chemotherapy of Breast Cancer

  2017cites this paper